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ARTICLE
Mutations in the KIAA0196 Gene at the SPG8 Locus Cause
Hereditary Spastic Paraplegia
Paul N. Valdmanis,* Inge A. Meijer,* Annie Reynolds, Adrienne Lei, Patrick MacLeod,
David Schlesinger, Mayana Zatz, Evan Reid, Patrick A. Dion, Pierre Drapeau, and Guy A. Rouleau
Hereditary spastic paraplegia (HSP) is a progressive upper-motor neurodegenerative disease. The eighth HSP locus, SPG8,
is on chromosome 8p24.13. The three families previously linked to the SPG8 locus present with relatively severe, pure
spastic paraplegia. We have identified three mutations in the KIAA0196 gene in six families that map to the SPG8 locus.
One mutation, V626F, segregated in three large North American families with European ancestry and in one British
family. An L619F mutation was found in a Brazilian family. The third mutation, N471D, was identified in a smaller
family of European origin and lies in a spectrin domain. None of these mutations were identified in 500 control indi-
viduals. Both the L619 and V626 residues are strictly conserved across species and likely have a notable effect on the
structure of the protein product strumpellin. Rescue studies with human mRNA injected in zebrafish treated with mor-
pholino oligonucleotides to knock down the endogenous protein showed that mutations at these two residues impaired
the normal function of the KIAA0196 gene. However, the function of the 1,159-aa strumpellin protein is relatively
unknown. The identification and characterization of the KIAA0196 gene will enable further insight into the pathogenesis
of HSP.
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Hereditary spastic paraplegia (HSP) has a worldwide prev-
alence of 1–18 in 100,0001–3 and is characterized by cen-
tral-motor-system deficits leading to lower-limb spastic
paraperesis.4–6 This is due to a “dying back” phenomenon
whereby upper motor neurons degenerate progressively,
commencing with the longest axons.7,8 HSP can be clas-
sified into pure and complicated forms.5 In pure HSP,
lower-limb spasticity is the only major symptom. Alter-
natively, in complicated HSP, this spasticity can be accom-
panied by other neurological or nonneurological symp-
toms, such as ataxia, dementia, mental retardation, deaf-
ness, epilepsy, ichthyosis, retinopathy, ocular neuropathy,
and extrapyramidal disturbances.5,9 There is clinical het-
erogeneity within families, where age at onset and severity
can differ markedly; between families that map to the
same locus; and certainly between families that map to
separate loci. This heterogeneity complicates genotype-
phenotype correlations for HSP.
HSP is also extremely genetically heterogeneous. From
130 loci mapped (SPG1–33), 11 genes have been identi-
fied. This disease can be transmitted in a dominant (13
loci), a recessive (15 loci), or an X-linked manner (4 loci).9–
11 By far, the most common locus for the disease is SPG4
(MIM 604277), with mutations in the microtubule-sev-
ering protein spastin accounting for ∼40% of dominant
HSP cases.12,13
Families that map to SPG8 are considered to have one
of the more aggressive subtypes of HSP, with disease onset
occurring for patients as early as their 20s or 30s. It was
first identified in a white family as a 6.2-cM region between
markers D8S1804 and D8S1774.14 The family had 15 pa-
tients affected with spasticity, hyperreflexia, extensor plan-
tar reflexes, lower-limb weakness, decreased vibration sen-
sation, and limited muscle wasting. The candidate region
was further reduced to 3.4 cM because of a lower recom-
binant in a second family, which narrows the interval be-
tween markers D8S1804 and D8S1179.15 This family, as
well as a third Brazilian family linked to SPG8, also pre-
sented with pure adult-onset HSP.16 For two of the families,
a muscle biopsy was performed14,16; however, no gross his-
tological or histochemical abnormalities were observed.
Ragged red fibers have been observed in muscle biopsies of
patients with HSP who have paraplegin mutations.17
In the present study, we identified four additional fam-
ilies that are linked to the SPG8 locus. Genes were screened
in an expanded candidate SPG8 locus defined by these
four families, along with the British and Brazilian fami-
lies described above.15,16 This led to the identification of
three point mutations in the KIAA0196 gene encoding
the strumpellin protein product.
Material and Methods
Subjects
Protocols were approved by the Ethics Committee of the Centre
Hospitalier de l’Universite´ de Montre´al. Patients gave informed
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Table 1. Primers and Amplification
Conditions for KIAA0196
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
consent, after which patient information and blood was collected.
DNA was extracted from peripheral blood through use of standard
protocols.
Genotyping and Locus Exclusion
PCR-amplified fragments incorporating a-35S–2-deoxyadenosine
5-triphosphate were resolved on 6% denaturing polyacrylamide
gels. Alleles were run alongside an M13mp18 sequence ladder
and were scored on the basis of allele sizes and frequencies from
the Fondation Jean Dausset-CEPH database. LOD-score calcula-
tions and multipoint analysis were performed using the MLINK
program of the LINKMAP software package.18
Mutation Screening
The 28 exons of KIAA0196 were screened by automated sequenc-
ing, including at least 50 bp of each intronic region. Primers were
designed using the PrimerSelect program (Lasergene) and were
synthesized by Invitrogen Canada. Primer sequences and ampli-
fication conditions for each exon are listed in table 1.
Variants were first tested in 12 control individuals by sequenc-
ing, followed by allele-specific oligomerization (ASO).19,20 In brief,
4 ml of PCR product was hybridized onto Hybond-N Nylon
membranes (Amersham Biosciences) by use of a dot-blot appa-
ratus. P32-labeled probes specific to the mutation or normal se-
quence were hybridized and then visualized on autoradiographic
film after overnight exposure. ASO primers for exon 11 are 5′-
ACTAGAAAACCTTCAAGCT-3′ (normal) and 5′-ACTAGAAGACC-
TTCAAGCT-3′ (mutated). For exon 14, ASO primers of 5′-GGAGA-
GTTGGTATC-3′ (normal) and 5′-GGAGAGTTCGTATC-3′ (mu-
tated) were used. Exon 15 ASO primers were 5′-CACTGAAGGTT-
TTG-3′ (normal) and 5′-CACTGAAGTTTTTG-3′ (mutated).
Protein-Sequence Alignment
Cluster analysis was performed using the Probcons (v. 1.09) pro-
gram. Proteins from aligned species included Homo sapiens
(Q12768), Canis familiaris (GenBank accession number XP_
532327), Pan troglodytes (GenBank accession number XP_519952),
Drosophila melanogaster (GenBank accession number CG12272),
Caenorhabditis elegans (GenBank accession number CE13235),
Xenopus tropicalis (GenBank accession number MGC89323), Rat-
tus norvegicus (GenBank accession number XP_343250), Danio re-
rio (GenBank accession number BC045490), Gallus gallus (Gen-
Bank accession number XP_418441), Dictyostelium discoideum
(GenBank accession number EAL63144), and Mus musculus (Gen-
Bank accession number NP_705776.2).
Homology Modeling
The size of the strumpellin protein (1,159 aa) made it prohibitive
to obtain a template for the entire protein. Instead, 200 aa (amino
acids 501–725) around the two mutations were selected and in-
putted in the Phyre program version 2.0 (Phyre Protein Fold Rec-
ognition Server). The template with the highest score was se-
lected—namely, 1dn1b from the Neuronal-Sec1 syntaxin 1a com-
plex. The SwissProt database viewer (v. 3.7)21 was used to visualize
the model, with concentration on the a-helix in which the two
mutations lie and on a second a-helix in nearby 3D space. Pep-
tides incorporating one or the other identified point mutation
were visualized in the same manner.
Expression Studies
Northern-blot and RT-PCR analyses.—The KIAA0196 cDNA pBlue-
script clone was kindly provided by the Kazusa DNA Research
Institute. A 1-kb probe specific to the C-terminal region of strum-
pellin was generated by digesting the KIAA0196 pBluescript vec-
tor with XhoI and NotI. Thirty micrograms of total RNA per sam-
ple was loaded. RNA was extracted from various regions of the
brain of a control individual. An RT-PCR was performed using
Moloney murine leukemia virus–reverse transcriptase (Invitro-
gen). Primers in exons 10 (forward) and 15 (reverse) of KIAA0196
were used. Glyceraldehyde-3-phosphate dehydrogenase cDNA
was amplified as a control.
Constructs
Each mutation was introduced into the KIAA0196 pBluescript
clone by site-directed mutagenesis through use of the primers 5′-
CTGGAGAGTTCGTATCCTATGTG-3′ for the exon 14 variant and
5′-CCTATGTGAGAAAATTTTTGCAGATC-3′ for the exon 15 vari-
ant, along with primers of their complementary sequence. Wild-
type and mutant KIAA0196 cDNAs were cloned, upstream of Myc
and His tags, into a pCS2 vector and were transcribed in vitro by
use of the SP6 mMESSAGE mMachine kit (Ambion) for zebrafish
studies. The protein expression from each of these constructs was
validated after their transient expression in cell (HeLa) culture
and subsequent western-blot analysis with an anti-Myc antibody.
A band at the appropriate height (∼134 kDa for strumpellin) was
observed.
Zebrafish Knockdown Studies
Morpholino injections.—Wild-type zebrafish were raised and mated
as described elsewhere.22 Antisense morpholinos (AMOs) were pur-
chased from Genetools. The morpholino sequences were designed
against the zebrafish strumpellin ortholog BC045490. The oli-
gonucleotide CTCTGCCAGAAAATCAC(CAT)GATG (KIAA MO)
binds to the ATG of the KIAA0196 gene, which prevents its trans-
lation, and CTCTcCCAcAAAATgAg(CAT)cATG (CTL MO) is a 5-
bp mismatch control. AMO injections were performed as de-
scribed elsewhere, at a concentration of 0.8 mM.23 The rescue
injections were performed as mentioned above, with morpholino
and mRNA concentrations of 0.8 mM and 50 ng/ml, respectively.
Immunohistochemistry.—Standard protocols were used for im-
munohistochemistry.22 In brief, 3-d-old embryos were fixed in 4%
paraformaldehyde, were washed, and were blocked at room tem-
perature. Primary antibody (anti-acetylated tubulin; 1:50 [Sigma])
was added overnight. After extensive washing, the embryos were
incubated with the fluorescently labeled secondary antibody Al-
exa 568 (Molecular Probes). Imaging was performed on an Ultra-
View LCI confocal microscope (Perkin Elmer) with use of Metha-
morph Imaging software (Universal Imaging). The statistical
significance between the different conditions was calculated us-
ing a x2 test.
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Figure 1. Pedigrees for families with KIAA0196 mutations. A, Family FSP24. B, Family FSP29. C, Family FSP34. D, Family FSP91.
Blackened boxes represent affected individuals, and a diagonal line through the symbol means the individual is deceased. A vertical
blackened bar indicates an individual with an unconfirmed phenotype. Sex of each individual has been masked to preserve confidentiality.
Individuals marked “P” represent proximal recombinants; “D” represents the distal recombinant. An asterisk (*) indicates that DNA and
clinical information have been collected for the particular individual. The age at onset of affected individuals is listed below each
symbol, although this information is not available for each patient. All studied affected patients are heterozygous for a c.1956CrT
mutation (pedigrees A, B, and C) or a c.A1491G mutation (pedigree D) in KIAA0196.
Results
Clinical Information and Family Details
Family FSP24 with the SPG8 mutation is from British Co-
lumbia. It is composed of 13 members affected with a
spastic gait and lower-limb stiffness (fig. 1A); genetic in-
formation is available for 10 of them. Symptoms were first
observed in individuals between ages 35 and 53 years.
Intrafamilial phenotypic heterogeneity exists, as shown
by the symptoms presented and the range of disease se-
verity in patients. Deep-tendon reflexes were brisk or in-
creased, and decreased vibration sensation was also noted
in three patients. Occasional bladder-control problemswere
also observed. Walking aids were required for some indi-
viduals, whereas one is confined to a wheelchair. Together,
these features are consistent with a pure, uncomplicated
HSP similar to that described for other families linked to
the SPG8 locus. Family FSP29 is of European descent and
resides in the United States. There are 31 affected indi-
viduals in the family, and genetic information is available
for 10 of them (fig. 1B). Age at onset was quite variable,
with symptom onset ranging in patients from their 20s
to their 60s. The family was negative for mutations in the
spastin gene.
Linkage Analysis
Two large families that map to the SPG8 locus were iden-
tified. In family FSP24, seven markers spanning the can-
didate region from markers D8S586 to D8S1128 were ge-
notyped in the 18 individuals studied (fig. 1A). A disease
haplotype segregated with the disease in all 10 affected
individuals (table 2). A recombination event occurred in
one individual (fig. 1A) between markers D8S586 and
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Table 2. Haplotype Comparison between
SPG8-Linked Families
Marker
Position
(Mb)
Alleles Number for Family
FSP24 FSP29 FSP34
D8S586 121.2 1 11 11
D8S1804 124.8 5 3 3
D8S1832 125.4 2 2 Not typed
D8S1179 125.9 3 9 9
D8S1774 127.5 3 5 4
D8S1128 128.5 7 5 1
NOTE.—Flanking markers in the candidate region are
D8S1832 and D8S1774 for family FSP29. The KIAA0196
L619F mutation was at position 126.1 Mb for all three
families. The allele for rs2293890 (126.4 Mb) was G for
family FSP24 and was C for both families FSP29 and
FSP34.
Figure 2. Region spanning the SPG8 locus. A, Markers defining
the borders of each described family with the SPG8 mutation and
the scaled marker positions on chromosome 8q24.13. B, Candidate
region used to search for the SPG8 gene between markers D8S1804
and D8S1774. Genes in the region are shown in their observed
orientation. C, The 28-exon KIAA0196 gene, drawn to scale, with
the location of three mutations in exons 11, 14, and 15 highlighted.
D8S1804, which defined the proximal border of the locus
in this family. A lower recombinant was neither identified
nor searched for, since the haplotype extended beyond
the limits of the SPG8 locus. The maximum LOD score for
this family was 3.43 at , by use of CEPH allele fre-vp 0
quencies for the marker D8S1804, along with a maximum
multipoint of 4.20 at marker D8S1799.
The same seven markers tested in family FSP24 were
genotyped for family FSP29. A disease haplotype was es-
tablished for all 10 studied affected individuals; it included
many informative recombination events. The proximal
recombinant occurred between markers D8S1799 and
D8S1832 in three affected individuals (fig. 1B), and the
distal recombinant was between markers D8S1774 and
D8S1128 for another affected individual (fig. 1B). This
yielded a candidate interval of 3.15 Mb. The maximum
LOD score for this family was 5.62 ( ) for markervp 0
D8S1179 when CEPH allele frequencies were used. Mul-
tipoint analysis was also conducted for this family in this
region, which yielded a maximum LOD score of 6.73, 0.5
cM centromeric to the D8S1128 marker.
Gene Screening
The previously published SPG8 locus spanned 3.4 cM (1.04
Mb) between markers D8S1804 and D8S1179 on chromo-
some 8q23-8q24. We screened nine known genes sur-
rounding this candidate region, as annotated in the Uni-
versity of California–Santa Cruz Genome Browser (UCSC)
May 2004 update, along with many clustered ESTs and
mRNAs that aligned to the locus, without detecting a mu-
tation. Therefore, we opted to redefine the candidate
region on the basis of the critical interval determined by
an upper recombinant in our FSP29 family at marker
D8S1832, and a lower recombinant at D8S1774 was based
on published data (fig. 2A).14 This increased the size of the
region to 5.43 cM (3.15 Mb), a region that contains three
additional known genes (fig. 2B). These additional genes
were screened, and three mutations were identified in the
KIAA0196 gene (fig. 2C).
Mutation Analysis
A valinerphenylalanine mutation was identified in amino
acid 626 for families FSP24 and FSP29 (p.V626F) (fig. 3A).
All studied affected individuals from each family were
screened and were positive for this mutation. The same
mutation was also found to segregate in a British family.15
This GrT nucleotide change is at position 1956 of the
mRNA (GenBank accession number NM_014846.2). A to-
tal of 500 ethnically matched control individuals (400 from
North America and 100 from CEPH) were negative for this
mutation, on screening by a combination of ASO and se-
quencing. No unaffected members or spouse control in-
dividuals in any family were positive for the mutations.
A second mutation was identified in the Brazilian fam-
ily16 in exon 14, a GrC transition at position 1937 of
the mRNA (fig. 3B). This leucinerphenylalanine change
(p.L619F) is only 7 aa away from the V626F mutation. It
was not found, with use of ASO, in 500 controls.
The KIAA0196 gene was screened in probands from 24
additional dominant HSP–affected families that are nega-
tive for mutations in both spastin and atlastin, resulting
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Figure 3. Mutation analysis of the KIAA0196 gene. A–C, Sequence trace of a patient with HSP above the sequence trace of a control
individual. Exon 15 (A), 14 (B), and 11 (C) heterozygous point mutations are indicated. D, Multiple-sequence alignment for strumpellin
homologues surrounding the two coding changes (boxed). The Probcons (v.1.09) program was used for cluster analysis. E, RT-PCR of
multiple brain regions performed using a KIAA0196-specific probe. F, Northern blot of the KIAA0196 transcript performed using 30 mg
of total RNA and a 1-kb C-terminal probe.
in the identification of two more families with missense
mutations in the KIAA0196 gene. Thus, the frequency of
mutations in our SPG3A- and SPG4-negative autosomal
dominant cohort is ∼8% (2 of 24). FSP34 has the same
p.V626F change in its three affected studied family mem-
bers. This family is originally from Great Britain and re-
sides in Canada (fig. 1C). Haplotype analysis of this family
with markers D8S1804, D8S1179, D8S1774, and D8S1128
indicated that there is allele sharing between this family
and family FSP29, which suggests an ancestral haplotype
(table 2). An additional mutation was found in three af-
fected siblings of another North American family of Eu-
ropean origin, family FSP91 (fig. 1D). This c.A1491G tran-
sition results in an asparagineraspartate amino acid change
(p.N471D) and is not present in the 500 controls tested
(fig. 3C).
Mutated amino acids at positions 619 and 626 are
strictly conserved across all 11 examined species, from
human to the social amoeba, D. discoideum (fig. 3D). In-
deed, the entire region surrounding these two mutations
appears to be functionally relevant for the protein, since
73 consecutive aa (amino acids 576–649) are 100% iden-
tical in the human, dog, chicken, mouse, rat, and orang-
utan. Despite this high level of conservation, this region
is an unknown domain, on the basis of searches of the
National Center for Biotechnology Information (NCBI)
Conserved Domain Database, NCBI BLAST, and the Sanger
Institute’s Pfam database. Position 471 is conserved across
all species except D. melanogaster (with a glutamine resi-
due) and X. tropicalis (with a histidine residue).
The exon 15 mutation is in the very first nucleotide of
the exon, which leads to the speculation that the splicing
of this exon might be compromised in our study families.
Splice-site prediction programs, including NetGene2, sug-
gested that the strength of the splice-site acceptor may be
reduced by 33% in the mutant form. However, both nor-
mal and mutant alleles were observed in cDNA analysis,
with use of several pairs of primers, of patient lympho-
blasts. The KIAA0196 gene was expressed ubiquitously, in-
cluding all regions of the brain that were examined by RT-
PCR (fig. 3E). There were no alternative splice isoforms
detected in control brain samples or patient whole-blood
samples by RT-PCR and northern-blot analysis (fig. 3E
and 3F). For the full KIAA0196 gene, all spliced ESTs and
mRNAs from the UCSC browser, May 2004 draft, were
analyzed for potential alternative splice products. One al-
ternative first exon often appears; however, of the 356
entries, only 2 (AK223628 and DA202680) contain exons
that are skipped. Thus, overall, the gene is not frequently
spliced, and the two spliced entries may represent spurious
transcripts.
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Figure 4. Three-dimensional modeling of strumpellin, with d1dn1b
as a template, through use of SwissProt database viewer. Two
helices from the 1,159-aa protein are shown, including amino acids
614–634 in one a-helix and amino acids 662–672 from a nearby
a-helix in the antiparallel direction. A, Residues L619 and V626,
in the same orientation in an a-helix opposite a second helix in
an antiparallel direction. Only residue side chains that are closest
in physical space are shown. B, The L619F mutation adds a bulky
phenylalanine side group that likely exceeds the space available
between the two a-helices. C, V626F mutation. The e carbon of
the F626 aromatic ring impinges on Q666 and may force apart the
two a-helices.
Figure 5. Zebrafish knockdown and rescue of KIAA0196 function.
A, Gross morphological features of normal wild-type zebrafish, de-
picted at 3 dpf. B, Injection of a 5-bp mismatch morpholino (CTL
MO), which results in no obvious disease phenotype. C and D, KIAA
MO–injected fish with a severely curly tail (C) or with a slightly
curly tail (D). Their heart cavities are also enlarged, which is com-
monly seen in injected fish. E and F, Fish, injected with both KIAA
MO and normal human KIAA0196 mRNA, with partially developed
curly tail (F) or no effect at all (E), depending on the injected
quantity. G and H, Disease phenotype not alleviated when the KIAA
MO is injected with the mutant forms (#14 [panel G] and #15
[panel H]) of the human mRNA. These fish resemble the KIAA MO
fish (C and D).
KIAA0196 Profile
The KIAA0196 gene spans 59.7-kb pairs of genomic DNA,
is 28 exons long, and codes for a protein of 1,159 aa
(strumpellin). The European Bioinformatics Institute’s In-
terProScan program predicts a spectrin-repeat–containing
domain in amino acids 434–518. Thus, the mutation at
position 471 may abrogate the binding of the spectrin
domain with other spectrin-repeat–containing proteins.
In examination of the secondary structure by use of PSI-
PRED,24 74% of the protein is considered to be a-helical.
The program further predicts an a-helix in the protein
from amino acids 606–644, which encompasses the two
other mutations that have been identified.
Homology Modeling
Given the high proportion of KIAA0196 considered to be
a-helical, it is not surprising that the optimal homology-
modeling candidates are similar in secondary-structure
composition. This is true for 1dn1b, a stat-like t-SNARE pro-
tein neuronal-Sec1 syntaxin 1a complex. This is the most
appropriate model for strumpellin, according to the Phyre
program (Phyre Protein Fold Recognition Server). The two
mutated residues lie within an a-helix from amino acids
619–628 that is in close 3D proximity to another a-helix
from residues 665–670 (fig. 4A). A mutation in either Val-
626 or Leu-619 to a phenylalanine residue would appear to
have significant structural implications, given the change
in bulkiness between the residues. In addition, Tyr-622
points in the same direction from the a-helix residue. To
have two amino acids with aromatic rings in such a physical
proximity could force apart the alignment of the two a-
helices or induce alterations in the a-helix backbone. The
N471D mutation was identified well after the two other
mutations and so was not tested in homology modeling
or in subsequent zebrafish-rescue experiments.
Zebrafish-Rescue Experiments
To validate the functional phenotype of the SPG8 muta-
tions in vivo, we developed a zebrafish model. Morpho-
lino oligonucleotide knockdown of the KIAA0196 protein
ortholog in zebrafish (KIAA MO) resulted in an enlarged
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Table 3. Phenotype Profile from Zebrafish Morpholino Oligonucleotide Knockdown
Condition
Percentage (No.) of Zebrafish
TotalNormal
Slightly Curly
Tail
Severely Curly
Tail Dead
KIAA0196 morpholino 19.1 (34) 28.1 (50) 37.1 (66) 15.7 (28) 178
Control morpholino 56.1 (83) 24.3 (36) 7.4 (11) 12.2 (18) 148
Wild-type rescue 63.2 (127) 19.4 (39) 8.0 (16) 9.5 (9) 201
Mutant #14 rescue 16.0 (32) 37.0 (74) 36.0 (72) 11.0 (22) 200
Mutant #15 rescue 13.2 (29) 37.4 (82) 30.1 (66) 19.2 (42) 219
heart cavity, along with a curly-tail phenotype that se-
verely impaired the ability of the fish to swim properly.
The overall phenotype ranged in severity and was classi-
fied in three major groups: normal, slightly curly, and se-
verely curly. This phenotype was clearly visible after de-
chorionating by 1 d post fertilization (dpf). At 3 dpf, wild-
type zebrafish are ∼5 mm long, with a straight tail (fig.
5A). Fish injected with a mismatch-control morpholino
(CTL MO) were initially used to titer a KIAA MO–specific
nontoxic injection dose (fig. 5B). Injection of the KIAA
MO resulted in 66 (37%) of 178 fish with a severely curly
tail and 50 (28%) of 178 fish with a slightly curly tail (table
3 and fig. 5C and 5D). The KIAA MO fish had a signifi-
cantly different distribution of phenotypic groups com-
pared with those with CTL MO injections ( ). WhenP ! .001
wild-type human KIAA0196 mRNA was coinjected with
KIAA MO, the curly-tail phenotype was rescued to levels
comparable to CTL MO injections ( ) (fig. 5E andPp .51
5F). This suggests that, in zebrafish, human KIAA0196
mRNA can compensate for the loss of endogenous zebra-
fish mRNA. Conversely, coinjection of human KIAA0196
mRNA incorporating either the exon 14 or exon 15 mu-
tation failed to significantly rescue the phenotype (fig. 5G
and 5H). Injection of mutant exon 14 or exon 15 mRNA
alone (without morpholinos) did not lead to a curly-tail
phenotype or influence lethality in zebrafish, which sug-
gests that the two mutations do not exert a dominant
negative effect. Approximately 200 embryos were injected
per experimental condition (table 3). The difference in
distribution between KIAA MO injection alone and KIAA
MO coinjection with wild-type mRNA was significant
( ). Similarly, coinjection of wild-type mRNA versusP ! .001
either exon 14 or exon 15 mutant mRNA was significantly
different, with a P value !.001. There was no statistical
difference between the coinjection of the exon 14 mutant
and the exon 15 mutant ( ). On histochemical anal-Pp .10
ysis of the embryos by use of an antiacetylated tubulin
stain for growing axons, we found that the motor neurons
in the spinal cord did not develop normally (fig. 6). Motor-
neuron axons in fish injected with KIAA MO alone or with
the mutant mRNAs were shorter and showed abnormal
branching. The structure of interneurons in the spinal
cord was also different. The absence of the KIAA0196 gene
or mutations in this gene during early development thus
seemed to hamper axonal outgrowth.
Discussion
HSP is one of the most genetically heterogeneous diseases,
caused by mutations in at least 31 different genes. This
means that 10.1% of genes in the human genome can be
mutated and result in one predominant neurological out-
come: the degeneration of upper-motor-neuron axons.Four
families in this study share the same p.V626F mutation,
which suggests that the altered nucleotide is a mutation
hotspot. For one of these families,15 the KIAA0196 gene
lies just beyond its distal candidate boundary. However,
the flanking marker likely represents either a marker mu-
tation or genotyping error in this family, since the p.V626F
mutation is present in the supposed recombinant as well
as all other affected individuals.
An SPG8 mutation causes a pure form of HSP with rel-
atively little interfamilial variability in phenotype. Inter-
estingly, two missense mutations were identified in highly
conserved amino acids in a predicted a-helix. The helix
consists of a heptameric repeat, with hydrophobic residues
aligning in inaccessible regions at the center of the helix.
The hydrophobic lysine and valine amino acids are 7 aa
apart in the protein sequence; thus, it is expected that
they would be buried in the helix, close in 3D space (fig.
5A). When replaced by a bulky phenylalanine residue at
either position, the stability of the a-helix could very well
be disrupted.
The one known domain in strumpellin is a spectrin
repeat that consists of three a-helices of a characteristic
length wrapped in a left-handed coiled coil.25 These spec-
trin repeats appear in the spectrin/dystrophin/a-actinin
family. The spectrin proteins have multiple copies (15–20)
of this repeat, which can then form multimers in the cell.
Spectrin also associates with the cell membrane via spec-
trin repeats in the ankyrin protein. Likewise, four spectrin
repeats are found in a-actinin beside two N-terminal cal-
ponin homology domains that anchor the complex to
actin.26 This effectively connects the cell membrane with
the actin-cytoskeletal network. The stability and structure
of this network also provide appropriate routes for intra-
cellular vesicular transport, a mechanism already linked
to other mutated HSP genes. Proteins with three or fewer
spectrin repeats can be considered to have transient as-
sociation with the spectrin network. The single repeat in
strumpellin is more likely to be involved in docking with
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Figure 6. Immunohistochemical analysis of zebrafish with the KIAA0196 knockdown phenotype. A, Motor neurons in the ventral roots
of wild-type zebrafish, segmented and oriented at 3 dpf. The spinal cord consists of the cell bodies of motor neurons and interneuron
bundles. The picture was taken near the gut of the fish. B, Mismatch control has a motor-neuron distribution similar to the wild type.
C, E, and F, Zebrafish injected with KIAA MO (C) and fish coinjected with mutant mRNA (#14 [panel E] and #15 [panel F]), showing
shorter, branching motor neurons that are not oriented. D, Wild-type KIAA0196 mRNA coinjections with KIAA MO, which partially rescue
the motor-neuron phenotype. The axons are longer and oriented.
one of the cytoskeletal spectrin repeats, which could help
in protein localization or signal transduction. It will be
interesting to determine with which protein(s) strumpel-
lin interacts through its spectrin domain and, particularly,
how the mutation identified at the core of this domain
influences this potential interaction.
Proteins with a spectrin repeat have been identified in
other neurological disorders—most notably, dystrophin,
mutated in myotonic dystrophy (MIM 300377).27 The re-
peat also has been found in a form of cerebellar ataxia
(MIM 117210).28 b-III spectrin itself is found to be mutated
in spinocerebellar ataxia 5.29 Whereas none of the genes
mutated in HSP have a spectrin domain, L1CAM (SPG1)
has an indirect association.9,30 L1CAM is a single-pass
transmembrane protein with a glycosylated extracellular
component that facilitates the outgrowth and migration
of neurons in the corticospinal tract. The intracellular C-
terminus, however, binds to the spectrin-repeat–contain-
ing protein ankyrin that links the cell membrane to in-
tracellular spectrin. Thus, strumpellin, with its spectrin
domain, may also be involved in this process.
The only detail known so far about the human KIAA0196
gene is that it has previously been implicated in prostate
cancer.31 An increase in gene-copy number was assayed by
real-time quantitative PCR and FISH, which determined
110-fold overexpression of the gene in PC-3 prostate can-
cer lines and in approximately one-third of advanced pros-
tate cancers examined.31 How this relates to a spastic par-
aplegia phenotype is not clear.
Analysis of other species has provided some insight into
a potential function for KIAA0196. A 118-kDa homologue
of the strumpellin protein was identified as part of a TATA-
binding protein-related factor 2 (TRF2) complex in a Dro-
sophila nuclear extract.32 Eighteen proteins were pulled
down, along with TRF2, in this complex, including NURF
and SWI, with functions for chromatin remodeling and
transcription activation. TRF2 is selective for promoters
lacking TATA or CAAT boxes. One protein of the complex
is DREF, which binds to DRE elements common in con-
trolling genes involved in cell-cycle regulation and cell
proliferation.33,34
With little known about the function of KIAA0196, we
decided to test the functionality of the missense changes
with a zebrafish knockdown model. Interestingly, the KIAA
MO–injected fish showed a severe tail phenotype charac-
terized by abnormal motor-neuron outgrowth in the spi-
nal cord. The knocked-down zebrafish resembles other
mutants affecting midline development.35 Injection of
wild-type human KIAA0196 mRNA concurrently with ze-
brafish KIAA MO knockdown rescued the phenotype to
values not significantly different from a control morpho-
lino injection. However, coinjecting human KIAA0196
mRNA containing either the exon 14 or the exon 15 mu-
tation yielded a phenotype comparable to injection of
KIAA MO alone. These experiments demonstrate the im-
portance of the KIAA0196 gene in early development of
zebrafish and suggest that the two missense mutations
impair the normal function of strumpellin. Further char-
acterization of the KIAA0196 knockdown phenotype is
necessary to better understand the role of this gene in early
fish development—more precisely, in motor-neuron out-
growth. This phenotype is remarkably similar to what
was recently observed in SPG4 morpholino knockdown
experiments in the zebrafish36: motor-neuron-axon out-
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growth is impaired, and embryos also have a curly tail.
This is another instance in which a dominant adult-onset
disease in humans displays an embryonic phenotype in
the zebrafish. It can be hypothesized that a complete
knockdown of either SPG4 or SPG8 yields an embryonic
phenotype, whereas one copy of the gene is enough in
humans to remain at a subphenotypic state until adult
stages. Importantly, in both instances, it is the motor neu-
rons that are impaired.
The identification of KIAA0196 as the gene mutated in
SPG8 adds another component to the various genes al-
ready identified for the disease. Two missense mutations
in a conserved part of the protein have been identified,
including one mutation common to four families. Addi-
tional work will aid in clarifying the function of the pro-
tein and how it relates to other proteins implicated in HSP
and the overall disease pathogenesis. As more of the genes
involved in HSP emerge, the responsible pathways and
mechanisms of toxicity will be better understood. This will
also help in elucidating the pathophysiology of a related
disease—amyotrophic lateral sclerosis—in which the re-
duced life span of patients complicates the cloning of
genes by linkage analysis.
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